Christopher Autry
Pfizer (United States)(US)
Publications by Year
Research Areas
Cell Adhesion Molecules Research, HER2/EGFR in Cancer Research, Catalytic C–H Functionalization Methods, Angiogenesis and VEGF in Cancer, PI3K/AKT/mTOR signaling in cancer
Most-Cited Works
- → Cellular Characterization of a Novel Focal Adhesion Kinase Inhibitor(2007)482 cited
- → Design of Selective, ATP-Competitive Inhibitors of Akt(2010)75 cited
- → Trifluoromethylpyrimidine-based inhibitors of proline-rich tyrosine kinase 2 (PYK2): Structure–activity relationships and strategies for the elimination of reactive metabolite formation(2008)51 cited
- → A new catalytic transformation of diazo esters: hydride abstraction in dirhodium(II)-catalysed reactions(1995)40 cited
- → Abstract A86: Design, synthesis, and SAR of focal adhesion kinase (FAK) inhibitors(2009)2 cited
- → ChemInform Abstract: A New Catalytic Transformation of Diazo Esters: Hydride Abstraction in Dirhodium(II)‐Catalyzed Reactions.(1995)1 cited
- → Corrections to Design of Selective, ATP-Competitive Inhibitors of Akt(2010)1 cited
- Focal Adhesion Kinase: Targeting Adhesions Signals in Normal and Cancer Cells(2007)
- MEDI 340-Design, synthesis and evaluation of a potent class of spiroindoline pyrrolopyrimidines targeting Akt as anticancer agents(2007)
- Design, synthesis, activity and properties of selective inhibitors of focal adhesion kinase.(2006)